Sanara MedTech Inc. — Director's Dealing 2025

May 28, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2025-05-22

Reporting Person: Ortwein Sara N (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-22	Common Stock	A	3277	—	Acquired	20799	Direct

Footnotes

F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date.